Mental Health

  • Medical, ethical, and legal aspects of end-of-life dilemmas in the intensive care unit
    Jonathan Wiesen, MD, Christopher Donatelli, MD, Martin L. Smith, STD, Laurel Hyle, JD, MPH and Eduardo Mireles-Cabodevila, MD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 516-527; DOI: https://doi.org/10.3949/ccjm.88a.14126

    Three hypothetical cases elucidate medical, ethical, and legal considerations in common end-of-life situations encountered in the ICU.

  • How do you effectively evaluate the elderly for alcohol use disorder?
    Moronkeji Fagbemi, MD, FASAM
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 434-439; DOI: https://doi.org/10.3949/ccjm.88a.20123

    A brief review of clues to an underrecognized and underdiagnosed problem with physical as well as emotional and social consequences.

  • Antiobesity drug therapy: An individualized and comprehensive approach
    Yael Mauer, MD, MPH, Marcie Parker, PharmD, BCACP and Sangeeta R. Kashyap, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 440-448; DOI: https://doi.org/10.3949/ccjm.88a.20080

    As part of a comprehensive plan, these drugs can provide lasting obesity control and additional health benefits, including decreased cardiovascular risk.

  • The current state of tobacco cessation treatment
    Humberto K. Choi, MD, FCCP, Jorge Ataucuri-Vargas, MD, Charlie Lin, MD and Amanda Singrey, PharmD, BCACP, CTTS
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 393-404; DOI: https://doi.org/10.3949/ccjm.88a.20099

    Behavioral interventions and pharmacotherapy increase success rates. Alternative treatments should not replace or delay the use of known effective therapies.

  • Medical complications of bulimia nervosa
    Allison Nitsch, MD, Heather Dlugosz, MD, Dennis Gibson, MD and Philip S. Mehler, MD, FACP, FAED
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 333-343; DOI: https://doi.org/10.3949/ccjm.88a.20168

    Complications can affect all body systems, but especially the renal and electrolyte systems.

  • COVID-19: An unwelcome guest that won’t leave
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 254-255; DOI: https://doi.org/10.3949/ccjm.88b.05021

    Long-lasting economic and societal effects, and lingering post-infection symptoms.

  • Post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’
    Susan Vehar, MD, Marina Boushra, MD, Prince Ntiamoah, MD and Michelle Biehl, MD, MS
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 267-272; DOI: https://doi.org/10.3949/ccjm.88a.21010

    An estimated 10% of COVID-19 survivors continue to experience symptoms weeks to months after symptoms appear.

  • What is causing the ‘long-hauler’ phenomenon after COVID-19?
    Leonard H. Sigal, MD, FACP, FACR, MACR
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 273-278; DOI: https://doi.org/10.3949/ccjm.88a.21009

    We are still early in our understanding of COVID-19 and its many manifestations.

  • Vaccinating the unvaccinated adult
    Dillon Cason, MD and Paul Williams, MD, FACP
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 279-285; DOI: https://doi.org/10.3949/ccjm.88a.20046

    Numbers of unvaccinated children are on the rise, but when they grow up, some of them come in for care.

  • Quetiapine for primary insomnia: Consider the risks
    Vania Modesto-Lowe, MD, MPH, Agata K. Harabasz, MD and Sophia A. Walker, MD
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 286-294; DOI: https://doi.org/10.3949/ccjm.88a.20031

    Its cardiometabolic effects and potential for abuse warrant caution in off-label use.

Pages